We intend to test telomerase gene therapy to rejuvenate microglial cells in an Alzheimer’s Disease human study, building on promising research study data.
Research has shown that a novel therapeutic agent, a protein called Intermedin, can help by combating the ill effects of CKD. Find out more here.
In human DNA, certain genes are responsible for preventing cells from becoming cancerous.
IHS, in partnership with BioViva, is dedicated to providing you with the latest breakthroughs in medical technologies to help you at this difficult time in your life. Our doctors are here to help you every step of the way. To schedule your 30 minute doctor’s consultation, please click below. Our gene therapies begin at $75,000.
*Please note that the default length of an appointment is 30 minutes, and the cost is $357 USD. You have the option of scheduling more time.